Literature DB >> 11711867

Altered levels of the synaptosomal associated protein SNAP-25 in hippocampus of subjects with mood disorders and schizophrenia.

S H Fatemi1, J A Earle, J M Stary, S Lee, J Sedgewick.   

Abstract

SNAP-25 levels were measured in ventral hippocampus in subjects with unipolar depression (n = 12), bipolar disorder (n = 13), schizophrenia (n = 15) and controls (n = 15) using quantitative immunocytochemistry. SNAP-25 levels were reduced significantly in stratum oriens of bipolar patients compared with controls (p < 0.05); they were also reduced significantly in st. oriens (p < 0.01 vs schizophrenia), in alveous (p < 0.01 vs schizophrenia) and in presubiculum (p < 0.05 vs depressed). SNAP-25 levels were also reduced in several layers of schizophrenics, only significantly so in st. granulosum (p < 0.05 vs controls). In contrast, depressed SNAP-25 levels increased in st. moleculare (p < 0.01 vs schizophrenics) and presubiculum (p < 0.05 vs controls and bipolars; p < 0.01 vs schizophrenics). SNAP-25 values were not affected by age, sex, race, post-mortem interval, brain pH, side of brain, age of onset of disease, family history of psychiatric disease, drug or alcohol use, antipsychotic drug treatment, or mode of death. The reported changes in SNAP-25 levels appear to be disease specific, separating synaptic pathology in unipolar depression from that observed in schizophrenia and bipolar disorders.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11711867     DOI: 10.1097/00001756-200110290-00023

Source DB:  PubMed          Journal:  Neuroreport        ISSN: 0959-4965            Impact factor:   1.837


  48 in total

Review 1.  The hippocampus in schizophrenia: a review of the neuropathological evidence and its pathophysiological implications.

Authors:  Paul J Harrison
Journal:  Psychopharmacology (Berl)       Date:  2004-03-06       Impact factor: 4.530

2.  The effects of chronic treatment with mood stabilizers on the rat hippocampal post-synaptic density proteome.

Authors:  Dhaval Nanavati; Daniel R Austin; Lisa A Catapano; David A Luckenbaugh; Ayse Dosemeci; Husseini K Manji; Guang Chen; Sanford P Markey
Journal:  J Neurochem       Date:  2011-09-21       Impact factor: 5.372

3.  Fragile X mental retardation protein levels are decreased in major psychiatric disorders.

Authors:  S Hossein Fatemi; Rachel E Kneeland; Stephanie B Liesch; Timothy D Folsom
Journal:  Schizophr Res       Date:  2010-08-19       Impact factor: 4.939

4.  Differential activation of immune/inflammatory response-related co-expression modules in the hippocampus across the major psychiatric disorders.

Authors:  S Kim; Y Hwang; M J Webster; D Lee
Journal:  Mol Psychiatry       Date:  2015-06-16       Impact factor: 15.992

5.  Tyrosine kinase B protein expression is reduced in the cerebellum of patients with bipolar disorder.

Authors:  Benchawanna Soontornniyomkij; Ian P Everall; Gursharan Chana; Ming T Tsuang; Cristian L Achim; Virawudh Soontornniyomkij
Journal:  J Affect Disord       Date:  2011-05-25       Impact factor: 4.839

6.  Genome-wide association scan for five major dimensions of personality.

Authors:  A Terracciano; S Sanna; M Uda; B Deiana; G Usala; F Busonero; A Maschio; M Scally; N Patriciu; W-M Chen; M A Distel; E P Slagboom; D I Boomsma; S Villafuerte; E Sliwerska; M Burmeister; N Amin; A C J W Janssens; C M van Duijn; D Schlessinger; G R Abecasis; P T Costa
Journal:  Mol Psychiatry       Date:  2008-10-28       Impact factor: 15.992

7.  Association between polymorphisms in the vesicle-associated membrane protein-associated protein A (VAPA) gene on chromosome 18p and bipolar disorder.

Authors:  Falk W Lohoff; Andrew E Weller; Paul J Bloch; Aleksandra H Nall; Thomas N Ferraro; Wade H Berrettini
Journal:  J Neural Transm (Vienna)       Date:  2008-07-30       Impact factor: 3.575

8.  Differential expression of presynaptic genes in a rat model of postnatal hypoxia: relevance to schizophrenia.

Authors:  J U Sommer; A Schmitt; M Heck; E L Schaeffer; M Fendt; M Zink; K Nieselt; S Symons; G Petroianu; A Lex; M Herrera-Marschitz; R Spanagel; P Falkai; P J Gebicke-Haerter
Journal:  Eur Arch Psychiatry Clin Neurosci       Date:  2010-10-14       Impact factor: 5.270

Review 9.  Current research on respiratory viral infections: Fourth International Symposium.

Authors:  Michael G Ison; John Mills; Peter Openshaw; Maria Zambon; Albert Osterhaus; Frederick Hayden
Journal:  Antiviral Res       Date:  2002-08       Impact factor: 5.970

10.  Interaction between environmental and genetic factors modulates schizophrenic endophenotypes in the Snap-25 mouse mutant blind-drunk.

Authors:  Peter L Oliver; Kay E Davies
Journal:  Hum Mol Genet       Date:  2009-09-03       Impact factor: 6.150

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.